Detalles de la búsqueda
1.
Empowering SARS-CoV-2 variant neutralization with a bifunctional antibody engineered with tandem heptad repeat 2 peptides.
J Med Virol
; 96(3): e29506, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38445718
2.
Generation and Next-Generation Sequencing-Based Characterization of a Large Human Combinatorial Antibody Library.
Int J Mol Sci
; 24(6)2023 Mar 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36983085
3.
Bispecific Antibody-Based Immune-Cell Engagers and Their Emerging Therapeutic Targets in Cancer Immunotherapy.
Int J Mol Sci
; 23(10)2022 May 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35628495
4.
Targeting cell surface glucose-regulated protein 94 in gastric cancer with an anti-GRP94 human monoclonal antibody.
BMB Rep
; 57(4): 188-193, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38449302
5.
Development and Characterization of Phage Display-Derived Monoclonal Antibodies to the S2 Domain of Spike Proteins of Wild-Type SARS-CoV-2 and Multiple Variants.
Viruses
; 15(1)2023 01 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36680213
6.
A novel bispecific antibody dual-targeting approach for enhanced neutralization against fast-evolving SARS-CoV-2 variants.
Front Immunol
; 14: 1271508, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37822941
7.
Novel bispecific human antibody platform specifically targeting a fully open spike conformation potently neutralizes multiple SARS-CoV-2 variants.
Antiviral Res
; 212: 105576, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36870394
8.
An internalizing antibody targeting of cell surface GRP94 effectively suppresses tumor angiogenesis of colorectal cancer.
Biomed Pharmacother
; 150: 113051, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35658213
9.
Development and Characterization of Phage-Display-Derived Novel Human Monoclonal Antibodies against the Receptor Binding Domain of SARS-CoV-2.
Biomedicines
; 10(12)2022 Dec 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36552031
Resultados
1 -
9
de 9
1
Próxima >
>>